Regulatory Affairs Solutions for Pharma
Assyro AI empowers regulatory affairs professionals in pharmaceutical companies with intelligent regulatory tools. RA professionals spend 60% of their time on manual drafting, formatting, and regulatory tracking instead of strategic work. Assyro automates the grind so you focus on the decisions that actually move submissions forward.
What Regulatory Affairs Teams Do
- Preparing and submitting regulatory dossiers to health authorities
- Tracking regulatory guidance and policy changes
- Maintaining product registrations and renewals
- Advising on regulatory strategy and pathways
- Coordinating with health authorities on submissions and inquiries
Challenges in Pharma
- 10+ hours per week spent manually tracking regulatory changes across multiple agencies
- Document drafting and formatting consumes 60% of time that should go to strategic work
- Submission timelines and milestones are tracked in spreadsheets that are always outdated
- Cross-functional teams misalign on Module 2 summaries weeks before submission lock
- Manual eCTD assembly creates structural defects caught too late to fix cleanly
How Assyro AI Helps
- Cut regulatory intelligence tracking from 10+ hours/week to automated, real-time alerts
- Draft submission documents 14x faster with AI that understands clause-level requirements
- Validate eCTD formatting continuously as your team works, not as a final step
- Cut NDA and sNDA prep time by 60% with AI-assisted drafting and automated readiness checks
- Validate eCTD sequences in real time against FDA technical specs before gateway dispatch
Key Skills We Support
Regulations We Cover
Frequently Asked Questions
RA teams using Assyro recover 100+ hours per submission cycle by automating drafting, validation, and regulatory tracking. That's time redirected from manual formatting to strategic regulatory work.
No. Assyro handles the manual grind (drafting, formatting, tracking, validation) so your RA team focuses on what only humans can do: regulatory strategy, authority relationships, and judgment calls.
One dashboard shows every program's readiness status, deadlines, and open tasks. RA teams using Assyro handle 3x the submission volume at the same quality bar without adding headcount.
Teams using Assyro draft regulatory documents 14x faster and cut validation time by 50%. On a typical NDA cycle, that translates to 100+ recovered hours and $150-250K in avoided rework, contractor fees, and delayed revenue.
Yes. Assyro supports all major FDA submission types with pre-configured workflows for each. The same execution system handles original applications, supplements, amendments, and annual reports.
Regulatory Context
Regulatory Affairs teams in Pharma depend on current regulatory intelligence to keep submissions, quality narratives, and inspection responses aligned with health-authority expectations.
Common Mistakes
- Treating submission quality as a final publishing step instead of a continuous process.
- Reusing precedent language without checking current jurisdiction updates.
- Weak linkage between strategy assumptions and dossier evidence.
Key Regulatory Terms
A standardized electronic format for organizing and submitting regulatory applications to health authorities worldwide.
A formal request to the FDA for approval to market a new pharmaceutical drug in the United States.
An application to the FDA to begin clinical trials of a new drug in humans.
An internationally harmonized format for organizing pharmaceutical regulatory submissions into five standardized modules.
Relevant Regulatory Intelligence
Related Actions
Other Roles in Pharma
Regulatory Affairs in Other Industries
Ready to Transform Your Regulatory Affairs Operations?
See how Assyro AI can accelerate regulatory work for regulatory affairs professionals in pharmaceutical companies.
Schedule a Demo